This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Chengdu Di'ao Jiuhong Pharmaceutical Factor. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations of Xiangyang Peng in Pharmaceutical Development
Introduction
Xiangyang Peng is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicaments aimed at increasing leucocytes and platelets. His innovative approach utilizes natural compounds, making his work both accessible and impactful.
Latest Patents
Xiangyang Peng holds a patent for the "Use of ursolic acid saponin, oleanolic acid saponin in preparation of increasing leucocytes and/or platelet medicine." This invention provides a method for using ursolic acid saponin and oleanolic acid saponin in the preparation of medicaments that enhance leucocyte and platelet counts. The invention also includes a pharmaceutical composition containing these compounds. The use of inexpensive and readily available natural plant materials as raw materials is a key feature of this innovation. Pharmacological tests have demonstrated that the compound exhibits significant activity in increasing leucocytes and/or platelets.
Career Highlights
Xiangyang Peng is associated with Chengdu Di'ao Jiuhong Pharmaceutical Factory, where he continues to advance his research and development efforts. His work is characterized by a commitment to utilizing natural resources for medicinal purposes, which aligns with current trends in sustainable and effective healthcare solutions.
Collaborations
Xiangyang Peng collaborates with esteemed colleagues such as Junjian Liu and Meirong Zhou. Their combined expertise enhances the research and development processes within their pharmaceutical endeavors.
Conclusion
Xiangyang Peng's innovative contributions to the pharmaceutical industry highlight the potential of natural compounds in medicine. His work not only addresses critical health needs but also promotes the use of sustainable resources in drug development.